ATE465716T1 - Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis - Google Patents

Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis

Info

Publication number
ATE465716T1
ATE465716T1 AT04710372T AT04710372T ATE465716T1 AT E465716 T1 ATE465716 T1 AT E465716T1 AT 04710372 T AT04710372 T AT 04710372T AT 04710372 T AT04710372 T AT 04710372T AT E465716 T1 ATE465716 T1 AT E465716T1
Authority
AT
Austria
Prior art keywords
pvp
atopic dermatitis
treat atopic
iodine liposomes
liposomes
Prior art date
Application number
AT04710372T
Other languages
English (en)
Inventor
Karen Reimer
Wolfgang Fleischer
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE465716T1 publication Critical patent/ATE465716T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04710372T 2003-02-24 2004-02-12 Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis ATE465716T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003283A EP1449521A1 (de) 2003-02-24 2003-02-24 Verwendung von PVP-Jod zur Behandlung von atopischer Dermatitis
PCT/EP2004/001317 WO2004073683A1 (en) 2003-02-24 2004-02-12 Use of pvp-iodine liposomes for treatment of atopic dermatitis

Publications (1)

Publication Number Publication Date
ATE465716T1 true ATE465716T1 (de) 2010-05-15

Family

ID=32731524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04710372T ATE465716T1 (de) 2003-02-24 2004-02-12 Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis

Country Status (8)

Country Link
EP (2) EP1449521A1 (de)
AR (1) AR043247A1 (de)
AT (1) ATE465716T1 (de)
DE (1) DE602004026830D1 (de)
ES (1) ES2345104T3 (de)
TW (1) TW200503778A (de)
UY (1) UY28198A1 (de)
WO (1) WO2004073683A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041859A1 (en) * 2005-04-08 2009-02-12 Mie University Wound Treatment Drugs for External Use
CN102335142B (zh) * 2011-10-25 2014-03-26 上海理工大学 一种能够原位自组装成难溶药物的纳米脂质体的复合微球及其制备方法
WO2016209966A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
US11273175B2 (en) * 2017-06-26 2022-03-15 Next Science IP Holdings Pty Ltd Method for treating fibrillar collagenous conditions
CN112206322A (zh) * 2020-11-13 2021-01-12 深圳先进技术研究院 杀菌剂及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364749B1 (en) * 1999-05-27 2008-04-29 Euro-Celtique, S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents

Also Published As

Publication number Publication date
ES2345104T3 (es) 2010-09-15
DE602004026830D1 (de) 2010-06-10
AR043247A1 (es) 2005-07-20
TW200503778A (en) 2005-02-01
EP1596826B1 (de) 2010-04-28
UY28198A1 (es) 2004-08-31
EP1449521A1 (de) 2004-08-25
WO2004073683A1 (en) 2004-09-02
EP1596826A1 (de) 2005-11-23

Similar Documents

Publication Publication Date Title
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE534379T1 (de) Neue verwendung von peptid-verbindungen zur behandlung von muskelschmerzen
ATE308364T1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE513550T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
ATE490825T1 (de) Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation
ATE473753T1 (de) Verwendung von botulinum toxin zur behandlung von post-operative schmerzen
ATE452642T1 (de) Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE518841T1 (de) Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas
DE602004008069D1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
ATE509621T1 (de) Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen
ATE353218T1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE60322898D1 (de) Verwendung von isoflavonen zur förderung des schlankheitseffekts
EP1965827A4 (de) Behandlung von entmyelinisierenden erkrankungen
DE602006021192D1 (de) Visnadin zur Behandlung von Kopfhautjucken
ATE465716T1 (de) Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis
DE602005015297D1 (de) Verwendung von ozon zur verbesserung des knetvorgangs
ATE418337T1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden
ATE483460T1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
ATE317261T1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
DE60103503D1 (de) Verwendung von fsh zur behandlung von infertilität
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties